Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services tags : Covid-19 save search
Bioxytran’s Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19
Published: 2024-02-21 (Crawled : 13:00) - globenewswire.com
BIXT A | $0.1285 490.75% 32K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.09%
C: -5.9%
covid-19 drug antiviral trial
Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
VERV | News | $6.64 -0.3% -0.3% 1.1M
|
Professional, Scientific, and T...
|
| O: 0.37%
H: 0.64%
C: -10.76%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.46%
H: 0.46%
C: -0.23%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.01%
H: 0.03%
C: -3.14%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 0.91%
H: 1.08%
C: -1.44%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -2.81%
ARCT 4 | $25.995 -1.23% -1.25% 630K
|
Health Technology
|
| O: -0.36%
H: 0.79%
C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market
Introducing the New HealthLynked COVID-19 Tracker: A Comprehensive Tool for the Modern Pandemic Era
Published: 2023-10-12 (Crawled : 12:00) - prnewswire.com
HLYK | $0.05 18.98% 320K
|
Professional, Scientific, and T...
|
| O: 1.36%
H: 8.88%
C: -1.34%
covid-19
Bioxytran Initiates a Registrational Trial of Oral ProLectin-M for Mild to Moderate COVID-19 Patients
Published: 2023-08-08 (Crawled : 11:00) - globenewswire.com
BIXT A | $0.1285 490.75% 32K
|
Professional, Scientific, and T...
|
| O: -8.77%
H: 13.02%
C: 12.77%
covid-19 trial
Bioxytran Peer-Reviewed Journal in “Vaccines” Contains Mechanism Capable of Targeting Future COVID-19 Mutations
Published: 2023-06-27 (Crawled : 11:00) - globenewswire.com
BIXT A | $0.1285 490.75% 32K
|
Professional, Scientific, and T...
|
| O: -5.76%
H: 20.74%
C: 20.74%
covid-19
Pardes Biosciences Announces Top-line Results from Phase 2 Trial Evaluating Pomotrelvir for the Treatment of COVID-19
Published: 2023-04-03 (Crawled : 16:00) - biospace.com/
PRDS | $2.16 1.37% 2.4M
|
Professional, Scientific, and T...
|
| O: -11.36%
H: 28.21%
C: 22.22%
covid-19 treatment trial results phase 2
Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment
Published: 2023-02-28 (Crawled : 13:00) - globenewswire.com
SBFM | News | $1.765 -46.84% -88.1% 11M
|
Professional, Scientific, and T...
|
| O: 1.16%
H: 4.34%
C: -1.03%
covid-19 treatment biopharma license
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
GRNA | $0.2995 -0.03% -0.07% 0
|
Professional, Scientific, and T...
|
| O: 6.24%
H: 0.0%
C: -5.87%
covid-19 candidate vaccine mrna trial approval
Cloud ERP Market Research Report by Component, Function Type, Organization Size, Verticals, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2023-01-05 (Crawled : 15:00) - prnewswire.com
SGGEF | $14.59 -47.52% 330
|
Technology Services
|
| O: -0.99%
H: 0.06%
C: 0.06%
SAPGF | News | $181.104 -19.46% 1.2K
|
Technology Services
|
| O: 0.68%
H: 0.14%
C: -0.58%
SGPYY | $57.82 3.25% 13K
|
Professional, Scientific, and T...
|
| O: -1.12%
H: 1.43%
C: -0.12%
SAP | News | $175.77 -1.61% 0.0% 950K
|
Technology Services
|
| O: 0.39%
H: 0.03%
C: -1.07%
ORCL | $114.88 -0.97% 0.01% 8.2M
|
Technology Services
|
| O: 0.62%
H: 0.47%
C: -0.81%
WDAY S | $252.12 -1.38% -1.4% 1.5M
|
Technology Services
|
| O: -2.16%
H: 0.0%
C: -4.38%
MSFT | News F | $399.09 -1.28% -1.3% 29M
|
Technology Services
|
| O: -0.83%
H: 0.15%
C: -2.15%
covid-19 research global report impact market cloud
Crystal Research Update Highlights 100% Responders Rate in Mild to Moderate COVID-19 Trial
Published: 2022-12-28 (Crawled : 12:20) - globenewswire.com
BIXT A | $0.1285 490.75% 32K
|
Professional, Scientific, and T...
|
| O: 5.24%
H: 45.04%
C: 20.03%
covid-19 research trial update
Virus Filtration Market Research Report by Product, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-27 (Crawled : 16:00) - prnewswire.com
LZAGF | $563.5 -19.1% 6
|
Health Technology
|
| O: -1.74%
H: 2.03%
C: 2.03%
LZAGY | $55.65 0.02% 32K
|
Professional, Scientific, and T...
|
| O: 0.52%
H: 0.21%
C: -0.47%
covid-19 research global report impact virus market
Hearing Amplifiers Market Research Report by Product, Type, Sales Channels, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-26 (Crawled : 13:20) - prnewswire.com
GGNDF | $25.56 50.16% 260
|
n/a
| Email alert
Add to watchlist
GNNDY | $71.19 75.95% 300
|
n/a
| Email alert
Add to watchlist
INND | $0.0003 33.33% 7.9M
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
covid-19 sales research global report impact market
Healthcare Testing, Inspection, & Certification Outsourcing Market Research Report by Product, Type, End-use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-26 (Crawled : 13:20) - prnewswire.com
IKTSF | News | $59.8723 -16.86% 990
|
Commercial Services
| Email alert
Add to watchlist
IKTSY | News | $59.97 -12.21% 88K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
covid-19 certification research global report impact market
Formulation Development Outsourcing Market Research Report by Service, Dosage Form, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-23 (Crawled : 14:00) - prnewswire.com
LZAGF | $563.5 -19.1% 6
|
Health Technology
|
| O: 0.67%
H: 0.02%
C: 0.02%
IKTSY | News | $59.97 -12.21% 88K
|
Professional, Scientific, and T...
|
| O: 4.57%
H: 1.01%
C: -1.87%
LZAGY | $55.65 0.02% 32K
|
Professional, Scientific, and T...
|
| O: 0.58%
H: 0.64%
C: -0.21%
CRL | $226.78 -0.34% 0.0% 410K
|
Commercial Services
|
| O: -0.02%
H: 0.36%
C: 0.08%
covid-19 research global report impact market
Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients
Published: 2022-12-08 (Crawled : 13:20) - biospace.com/
BIXT A | $0.1285 490.75% 32K
|
Professional, Scientific, and T...
|
| O: 4.78%
H: 0.0%
C: 0.0%
covid-19 approval
Worldwide In Vitro Diagnostic Tests Market Report 2022: COVID-19 Impacts, Summary, Regions of Market Influence, and What to Watch For Long-Term
Published: 2022-11-28 (Crawled : 12:00) - prnewswire.com
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 0.17%
H: 1.08%
C: -2.81%
TRIB | $1.81 -3.72% -3.87% 5.7K
|
Health Technology
|
| O: -3.01%
H: 8.53%
C: 4.65%
GH M | $16.08 -3.54% -3.67% 1.9M
|
Health Services
|
| O: -0.7%
H: 3.3%
C: -0.12%
CDNA | $8.32 3.1% 3.0% 500K
|
Health Technology
|
| O: -0.08%
H: 1.8%
C: -3.05%
TECH | $62.12 -0.15% -0.14% 910K
|
Health Technology
|
| O: -0.32%
H: 0.65%
C: -2.22%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -1.13%
H: 1.27%
C: -2.36%
AXDX | $0.8201 6.51% 6.1% 38K
|
Health Technology
|
| O: -0.75%
H: 2.55%
C: -7.82%
covid-19 report diagnostic market in vitro
Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print
Published: 2022-11-16 (Crawled : 13:00) - biospace.com/
BIXT A | $0.1285 490.75% 32K
|
Professional, Scientific, and T...
|
| O: 23.0%
H: 12.2%
C: -11.79%
covid-19 trial positive results
Molecular Partners Announces Presentation of the EMPATHY Study of Ensovibep for the Treatment of COVID-19 at ECCMID 2022
Published: 2022-04-23 (Crawled : 08:20) - globenewswire.com
MOLN | News | $3.74 -3.54% 6.2K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
covid-19 treatment ensovibep presentation molecular
mRNA Manufacturing and Synthesis Services Market worth $22.6 Billion by 2031- Growing Beyond COVID-19 Application
Published: 2022-02-10 (Crawled : 12:00) - prnewswire.com
LZAGF | $563.5 -19.1% 6
|
Health Technology
|
| O: -1.72%
H: 0.46%
C: -0.51%
LZAGY | $55.65 0.02% 32K
|
Professional, Scientific, and T...
|
| O: -1.31%
H: 2.63%
C: 0.75%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.7%
H: 3.82%
C: 0.78%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -2.42%
H: 0.49%
C: -2.63%
covid-19 application covid services growing
Global COVID-19 EIA/ELISA Medical Devices Market Landscape Report 2021: Comparative Analysis of the Products at Various Stages of Development
Published: 2022-01-18 (Crawled : 14:00) - prnewswire.com
OCDX | $17.63 0.45%
|
|
| O: -2.65%
H: 1.39%
C: -0.91%
IPA | $1.24 0.0% 150K
|
Professional, Scientific, and T...
|
| O: 0.32%
H: 2.22%
C: -1.59%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -2.15%
H: 0.0%
C: 0.0%
TECH | $62.12 -0.15% -0.14% 910K
|
Health Technology
|
| O: -4.04%
H: 0.39%
C: -1.01%
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 7.34%
H: 0.0%
C: 0.0%
covid-19 ces device covid report
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.